CLASS II Drug recall · Reported 30 May 2018 · FDA Enforcement Report

0.9% Sodium Chloride Injection recalled by Fresenius Medical Care Renal

Fresenius Medical Care Renal Therapies Group is recalling 0.9% Sodium Chloride Injection, USP, distributed nationwide in the US. The recall was initiated on 13 Nov 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 17LU05005; Exp. 09/18 Part Number 060-10109
Quantity recalled25,356 1 liter bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0827-2018
FDA event ID
79501
Classification
Class II
Status
Terminated
Recall initiated
13 Nov 2017
FDA classified
22 May 2018
Reported
30 May 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

13 Nov 2017Recall initiated by company
22 May 2018Classified by FDA+190 days
30 May 2018Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

0.9% Sodium Chloride Injection, USP, 1000 mL, Rx Only, Fresenius Medical Care North America, Waltham, MA 02451, NDC 49230-0300-10.

Where it was distributed

Product was distributed throughout the United States.

Nationwide

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility

Which lots are affected?

Lot # 17LU05005; Exp. 09/18 Part Number 060-10109

Where was it sold?

Product was distributed throughout the United States.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Fresenius Medical Care Renal Therapies Group

All 35

Other Sodium Chloride recalls

All 133